Neuropsychological profiles of adult bipolar disorder patients with and without comorbid attention-deficit hyperactivity disorder.

Attention-deficit/hyperactivity disorder Bipolar disorder Cognitive function Comorbidity Neuropsychology

Journal

International journal of bipolar disorders
ISSN: 2194-7511
Titre abrégé: Int J Bipolar Disord
Pays: Germany
ID NLM: 101622983

Informations de publication

Date de publication:
28 Jun 2019
Historique:
received: 27 02 2019
accepted: 14 06 2019
entrez: 29 6 2019
pubmed: 30 6 2019
medline: 30 6 2019
Statut: epublish

Résumé

Comorbid attention-deficit/hyperactivity disorder (ADHD) is common in bipolar disorder and associated with worse outcomes. Cognitive testing might be a tool to identify this group. Here we compare the neuropsychological profiles of bipolar disorder patients with (BD + cADHD) and without (BD - cADHD) childhood attention-deficit hyperactivity disorder. Adult patients with BD  -  cADHD (n = 66), BD + cADHD (n = 32), and healthy controls (n = 112) were tested using a comprehensive battery of neuropsychological tests. Patients underwent rigorous diagnostic assessments for bipolar disorder and ADHD, as well as a parental interview to establish childhood ADHD. The neuropsychological profiles of the groups were similar, except that the BD + cADHD group performed significantly worse on working memory. Working memory did not differ between those in the BD + cADHD group who only had a history of childhood ADHD and those that still met criteria for ADHD in adulthood. Cognitive testing had limited power to differentiate between bipolar disorder adults with and without childhood ADHD. The BD + cADHD subgroup cannot explain the significant cognitive heterogeneity seen in bipolar disorder patients.

Sections du résumé

BACKGROUND BACKGROUND
Comorbid attention-deficit/hyperactivity disorder (ADHD) is common in bipolar disorder and associated with worse outcomes. Cognitive testing might be a tool to identify this group. Here we compare the neuropsychological profiles of bipolar disorder patients with (BD + cADHD) and without (BD - cADHD) childhood attention-deficit hyperactivity disorder.
METHODS METHODS
Adult patients with BD  -  cADHD (n = 66), BD + cADHD (n = 32), and healthy controls (n = 112) were tested using a comprehensive battery of neuropsychological tests. Patients underwent rigorous diagnostic assessments for bipolar disorder and ADHD, as well as a parental interview to establish childhood ADHD.
RESULTS RESULTS
The neuropsychological profiles of the groups were similar, except that the BD + cADHD group performed significantly worse on working memory. Working memory did not differ between those in the BD + cADHD group who only had a history of childhood ADHD and those that still met criteria for ADHD in adulthood.
CONCLUSIONS CONCLUSIONS
Cognitive testing had limited power to differentiate between bipolar disorder adults with and without childhood ADHD. The BD + cADHD subgroup cannot explain the significant cognitive heterogeneity seen in bipolar disorder patients.

Identifiants

pubmed: 31250342
doi: 10.1186/s40345-019-0149-9
pii: 10.1186/s40345-019-0149-9
pmc: PMC6597668
doi:

Types de publication

Journal Article

Langues

eng

Pagination

14

Subventions

Organisme : Swedish Research Council
ID : 2018-02653
Organisme : Swedish Federal Government under the LUA/ALF agreement
ID : ALF 20170019
Organisme : Swedish Federal Government under the LUA/ALF agreement)
ID : ALFGBG-716801

Références

J Clin Child Psychol. 2001 Mar;30(1):48-58
pubmed: 11294077
J Abnorm Psychol. 2002 May;111(2):279-89
pubmed: 12003449
Am J Psychiatry. 2002 Nov;159(11):1882-8
pubmed: 12411223
Biol Psychiatry. 2003 Jun 1;53(11):1028-42
pubmed: 12788248
Neuropsychology. 2004 Jul;18(3):485-503
pubmed: 15291727
Eur Addict Res. 2005;11(1):22-31
pubmed: 15608468
Psychol Med. 2005 Feb;35(2):245-56
pubmed: 15841682
Biol Psychiatry. 2005 Jun 1;57(11):1467-73
pubmed: 15950022
Arch Clin Neuropsychol. 2005 Aug;20(6):727-44
pubmed: 15953706
Bipolar Disord. 2006 Apr;8(2):103-16
pubmed: 16542180
Biol Psychiatry. 2006 Nov 1;60(9):921-8
pubmed: 16839520
Acta Psychiatr Scand Suppl. 2007;(434):17-26
pubmed: 17688459
Psychol Med. 2008 Jun;38(6):771-85
pubmed: 17922938
J Clin Psychiatry. 2007 Nov;68(11):1776-84
pubmed: 18052572
J Atten Disord. 2008 May;11(6):628-41
pubmed: 18094324
Eur Arch Psychiatry Clin Neurosci. 2008 Oct;258(7):385-93
pubmed: 18437277
Curr Psychiatry Rep. 2008 Oct;10(5):407-11
pubmed: 18803914
Br J Psychiatry. 2009 Mar;194(3):243-51
pubmed: 19252155
Acta Psychiatr Scand. 2009 Sep;120(3):239-46
pubmed: 19426162
Bipolar Disord. 2010 Jun;12(4):351-63
pubmed: 20636632
Psychiatry Res. 2011 Apr 30;186(2-3):261-6
pubmed: 20832868
Bipolar Disord. 2011 Jun;13(4):334-42
pubmed: 21843273
Bipolar Disord. 2012 May;14(3):217-26
pubmed: 22548895
Compr Psychiatry. 2013 Jul;54(5):549-55
pubmed: 23306036
Acta Psychiatr Scand. 2013 Sep;128(3):149-62
pubmed: 23617548
Neuropsychology. 2013 May;27(3):287-302
pubmed: 23688211
BMC Psychiatry. 2013 Jun 07;13:165
pubmed: 23758923
Bipolar Disord. 2014 May;16(3):270-6
pubmed: 24286629
Psychiatry Res. 2014 May 15;216(2):269-76
pubmed: 24582774
J Affect Disord. 2014 Oct;168:161-6
pubmed: 25051093
Psychol Med. 2014 Oct;44(14):3083-96
pubmed: 25065409
J Psychiatr Pract. 2014 Nov;20(6):428-37
pubmed: 25406047
PLoS One. 2015 Jan 23;10(1):e0115562
pubmed: 25614986
Acta Psychiatr Scand. 2015 Nov;132(5):389-99
pubmed: 25900393
PLoS One. 2015 May 08;10(5):e0127100
pubmed: 25954806
Eur Neuropsychopharmacol. 2016 Aug;26(8):1338-47
pubmed: 27139077
Noro Psikiyatr Ars. 2016 Sep;53(3):257-262
pubmed: 28373804
Cogn Neuropsychiatry. 2017 Sep;22(5):407-421
pubmed: 28789589
Bipolar Disord. 2017 Dec;19(8):637-650
pubmed: 28941032
BMC Psychiatry. 2017 Dec 16;17(1):403
pubmed: 29246205
J Affect Disord. 2018 Mar 15;229:125-134
pubmed: 29306692
Acta Psychiatr Scand. 2018 Oct;138(4):325-335
pubmed: 29907968
Prog Neuropsychopharmacol. 1979;3(4):405-12
pubmed: 400996
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Am J Psychiatry. 1993 Jun;150(6):885-90
pubmed: 8494063
Am J Psychiatry. 1995 Dec;152(12):1793-9
pubmed: 8526248
Psychol Bull. 1997 Jan;121(1):65-94
pubmed: 9000892
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538

Auteurs

Sara Salarvan (S)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Blå Stråket 15, 413 45, Gothenburg, Sweden.

Timea Sparding (T)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Blå Stråket 15, 413 45, Gothenburg, Sweden.

Caitlin Clements (C)

Department of Psychology, University of Pennsylvania, 3720 Walnut Street, Philadelphia, PA, 19104, USA.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Center for Autism Research, The Children'S Hospital of Philadelphia, 2716 South St, Philadelphia, PA, 19104, USA.

Eleonore Rydén (E)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Mikael Landén (M)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Blå Stråket 15, 413 45, Gothenburg, Sweden. mikael.landen@gu.se.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. mikael.landen@gu.se.

Classifications MeSH